An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation

American Journal of Human Genetics

Volumn 62, Issue 6, 1998, Pages 1475-1483

  Bodmer, Daniëlle ^a   Eleveld, Marc J ^a   Ligtenberg, Marjolijn J L ^a   Weterman, Marian A J ^a   Janssen, Bert A P ^a   Smeets, Dominique F C M ^a   De Wit, Peter E J ^a   Van Den Berg, Anke ^b   Van Den Berg, Eva ^b   Koolen, Marianne I ^c   Van Kessel, Ad Geurts ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOME MOSAICISM; CARCINOGENESIS; CHROMOSOME 3; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; DELETION MUTANT; FAMILIAL DISEASE; FEMALE; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; NONDISJUNCTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS; VON HIPPEL LINDAU DISEASE;

EID: 17344368130     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/301888     Document Type: Article

References (37)

1. Beaudet AL, Tsui L-C (1993) A suggested nomenclature for designated mutations. Hum Mutat 2:245-248
2. Cohen A, Li F, Berg S, Marchetto D, Tsai S, Jacobs S, Brown R (1979) Hereditary renal cell carcinoma associated with chromosomal translocation. N Engl J Med 301:592-595
3. Decker HJH, Weidt EJ, Brieger J (1997) The von Hippel-Lindau tumor suppressor gene, a rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis. Cancer Genet Cytogenet 93:74-83
4. Foster K, Prowse A, van den Berg A, Fleming S, Hulsbeek MMF, Crossey PA, Richards FM, et al (1994) Somatic mutations of the von Hippel-Lindau disease tumor suppressor gene in non-familial clear cell renal carcinoma. Hum Mol Genet 3:2169-2173
5. Geurts van Kessel A, Tetteroo PAT, Von dem Borne AEGK, Hagemeijer A, Bootsma D (1983) Expression of human myeloid-associated surface antigens in human-mouse myeloid cell hybrids. Proc Natl Acad Sci USA 80:3748-3752
6. Gnarra JR, Lerman MI, Zbar B, Linehan WM (1995) Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis. Semin Oncol 22: 3-8
7. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, et al (1994) Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat Genet 7:85-90
8. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, et al (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91:9700-9704
9. Knudson AG (1993) Antioncogenes and human cancer. Proc Natl Acad Sci USA 90:10914-10921
10. _ (1995) VHL gene mutation and clear-cell renal carcinomas. Cancer J Sci Am 1:180-181
11. _ (1996) Hereditary cancer: two hits revisited. Cancer Res Clin Oncol 122:135-140
12. Kok K, Naylor SL, Buys CHCM (1997) Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 71:27-92
13. Koolen MI, Van der Meyden APM, Bodmer D, Eleveld M, Van der Looij E, Brunner H, Smits A, et al (1998) A familial case of renal cell carcinoma and a t(2;3) chromosome translocation. Kidney Int 53:273-275
14. Kovacs G (1993) Molecular cytogenetics of renal cell tumors. Adv Cancer Res 62:89-124
15. Kovacs G, Brusa P, De Riese W (1989) Tissue-specific expression of a constitutional 3;6 translocation development of multiple bilateral renal-cell carcinomas. Int J Cancer 43: 422-427
16. Kovacs G, Frisch S (1989) Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res 49:651-659
17. Kovacs G, Hoene E (1988) Loss of der(3) in renal carcinoma cell of a patient with constitutional t(3;12). Hum Genet 78: 148-150
18. Kovacs G, Kung HF (1991) Nonhomologous chromatid exchange in hereditary and sporadic renal cell carcinomas. Proc Natl Acad Sci USA 88:194-198
19. Li FP, Decker HH, Zbar B, Stanton VP, Kovacs G, Seizinger BR, Aburatani H, et al (1993) Clinical and genetic studies of renal cell carcinomas in a family with a constitutional chromosome 3;8 translocation: genetics of familial renal carcinoma. Ann Intern Med 18:106-111
20. Meloni AM, Bridge J, Sandberg AA (1992) Reviews on chromosome studies in urological tumors. J Urol 148:253-265
21. Motzer RJ, Bander NH, Nanus DM (1996) Renal-cell carcinoma. N Engl J Med 335:865-872
22. Ohta M, Inoue H, Cottecelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, et al (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597
23. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, et al (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68-73
24. Schmidt L, Li F, Brown RS, Berg S, Chen F, Wei MH, Tory K, et al (1995) Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation. Cancer J Sci Am 1:191-195
25. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, et al (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54:2852-2855
26. Sidhar SK, Clark J, Gill S, Hamoundi R, Crew AJ, Gwilliam R, Ross M, et al (1996) The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 5:1333-1338
27. Smith DI, Glover TW, Gemill RM, Drabkin HA, O'Connell P, Naylor SL (1995) Report of the Fifth International Workshop on Human Chromosome 3 Mapping 1994. Cytogenet Cell Genet 68:125-146
28. Spurr NK, Bashir R, Bushby K, Cox A, Cox S, Hildebrandt F, Hill N, et al (1996) Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996. Cytogenet Cell Genet 73:255-273
29. Stein WD, Stein AD (1995) Familial and sporadic human renal cell carcinoma: evidence against a double loss mechanism of carcinogenesis. J Clin Epidemiol 48:767-777
30. van den Berg A, Buys CHCM (1997) Involvement of multiple loci on chromosome 3 in renal cell cancer development. Genes Chromosom Cancer 19:59-76
31. van den Berg A, Draaijers TG, Kok K, Timmer T, Van der Veen AY, Veldhuis PMJF, De Leij L, et al (1997a) Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region. Genes Chromosom Cancer 19:220-227
32. van den Berg A, Hulsbeek MMF, De Jong D, Kok K, Veldhuis PMJF, Roche J, Buys CHCM (1996) Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. Genes Chromosom Cancer 15:64-72
33. van den Berg E, Dijkhuizen T, Oosterhuis JW, Geurts van Kessel A, De Jong B, Störkel S (1997b) Cytogenetic classification of renal cell cancer. Cancer Genet Cytogenet 95:103-107
34. Weterman M, Wilbrink M, Geurts van Kessel A (1996a) Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas. Proc Natl Acad Sci USA 93:15294-15298
35. Weterman M, Wilbrink M, Janssen I, Janssen H, van den Berg E, Fisher S, Craig I, et al (1996b) Molecular cloning of the papillary renal cell carcinoma-associated t(X;1)(p11;q21) breakpoint. Cytogenet Cell Genet 75:2-6
36. Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, Crossey PA, et al (1996) Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat 8:348-357
37. Zhuang Z, Gnarra JR, Dudley CF, Zbar B, Linehan WM, Lubensky IA (1996) Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens. Mod Pathol 9:838-842